Carbohydrate Antigen 19-9 Sales Market : Revenue Share, Insights & Future Outlook

What Is the Projected Growth of the Global Carbohydrate Antigen 19-9 Market?

The global Carbohydrate Antigen 19-9 market was valued at US$ 106 million in 2024 and is forecast to reach a readjusted size of US$ 163 million by 2031, growing at a CAGR of 6.4% during 2025-2031.

The global market is driven by increasing demand for early detection and monitoring of gastrointestinal cancers. CLIA (Chemiluminescent Immunoassay) represents the largest segment with over 70% market share, while ELISA remains an important diagnostic method.

Major manufacturers include Abbott, Roche, and Ortho Clinical Diagnostics, supplying high-quality immunoassay kits and testing solutions globally.

Download Free Data: https://reports.valuates.com/request/sample/QYRE-Auto-15N9124/Global_Carbohydrate_Antigen_19_9_Market_Outlook_2022?utm_source=Openpr&utm_medium=Referral

How Do Types of Carbohydrate Antigen 19-9 Tests Affect Market Dynamics?

The Carbohydrate Antigen 19-9 market is segmented by test type, with CLIA as the dominant segment due to its high sensitivity and efficiency, and ELISA representing a high-margin innovation option for laboratories and hospitals.

Segment by Type
• ELISA
• CLIA

Which Applications Are Driving Demand for Carbohydrate Antigen 19-9?

Key applications include pancreatic cancer, colon cancer, and stomach cancer diagnostics, with pancreatic cancer being the core demand driver. The growing prevalence of gastrointestinal malignancies and the need for early-stage diagnosis are primary factors boosting adoption.

Segment by Application
• Pancreatic Cancer
• Colon Cancer
• Stomach Cancer

Key Companies in the Carbohydrate Antigen 19-9 Market

• Abbott - Specializes in immunoassay diagnostics and clinical testing solutions.
• Roche - Known for high-precision laboratory diagnostics and CLIA-based assays.
• Ortho Clinical Diagnostics - Focuses on clinical laboratory testing and immunoassay kits.
• BioMérieux - Provides diagnostic solutions for oncology and infectious diseases.
• Fujirebio - Develops immunoassay reagents and clinical diagnostic systems.
• KAINOS Laboratories - Specializes in clinical laboratory testing and CA 19-9 assays.
• DiaSorin - Offers high-sensitivity immunoassay diagnostics.
• Danaher Corporation - Produces diagnostic equipment and reagents for laboratory testing.
• Siemens - Focused on laboratory diagnostics and automated immunoassay systems.
• Tellgen - Develops immunoassay kits for cancer biomarkers.
• DIACHA Diagnostics - Supplies clinical diagnostic reagents and assay kits.
• Sichuan Maccura Biotechnology - Produces immunodiagnostic products including CA 19-9 kits.
• Dirui - Specializes in clinical diagnostic instruments and reagents.
• Chemclin IVD - Provides high-quality in vitro diagnostic reagents and systems.

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-15N9124/global-carbohydrate-antigen-19-9?utm_source=Openpr&utm_medium=Referral

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.